EASD Berlin 2018 - Abstract

Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine). Diabetologia 2018, Vol.61 Supplement1: Abstract 747

C. Walton1, S. Kassim2, R. Harper3, P. McDonald3, U. Brennan3, J. Harding3, T. Htay4, R. Nayar5, A. Pernet6, S. Rowles7, K. Adamson8, K.Y. Thong9, R.E.J. Ryder10

1Hull Royal Infirmary, Hull, UK

Template for defining diabetes services during COVID-19 Pandemic

This template is based on the NHS ‘Clinical guide for the management of acute diabetes during the coronavirus pandemic’ ref 001559. The body of the document has been retained but space has been provided for you to populate to describe your local arrangements. In addition to the ‘blank’ template we have provided a specimen example which may be helpful. Clearly, arrangements will be different for different services and will depend on staff levels.  
We hope you will find this useful in planning diabetes services in the light of the existing NHS guidance.     

Liraglutide Audit DUK Annual Professional Conference, Manchester, March 13, 2013 - Slides

Does Liraglutide therapy affect the metabolic response in patients with elevated alanine aminotransferase and type 2 diabetes mellitus?

Piya Sen Gupta1, ABCD Research Fellow KY Thong1, M Cull1, P Winocour2, REJ Ryder1 on behalf of the ABCD nationwide liraglutide audit contributors

1City Hospital, Birmingham, UK

2QE 2 Hospital, Welwyn Garden City, UK

Exenatide & Liraglutide IDF Main Meeting, Dubai, December 6 2011 - Slides

Differences in response between exenatide and liraglutide in the Association of British Clinical Diabetologists (ABCD) nationwide audits

R.E.J. Ryder1, K.Y. Thong1, M.L. Cull1, A.P. Mills1, C. Walton2 on behalf of ABCD nationwide exenatide and liraglutide audits contributors

1City Hospital, Diabetes, Birmingham, UK

2Hull Royal Infirmary, Diabetes, Hull, UK

Subscribe to The Association of British Clinical Diabetologists